A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Pfizer

Status and phase: Withdrawn; Phase 2

Conditions: Diabetes Mellitus; Diabetic Retinopathy

Treatments: Drug: AG-014699

Study type: Interventional

Funder types: Industry

Identifiers

NCT00457470

A4991010

Details and patient eligibility

About

This study will evaluate the safety and efficacy of AG-014699 in diabetic patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diabetic patients, either man or woman, with diabetic retinopathy, at least 18 years of age

Exclusion criteria

• patients treated with laser therapy within the last 90 days
• patients with likelyhood to require cataract surgery within 3 months
• Uncontrolled diabetes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind